Crizotinib targets in glioblastoma stem cells.

Junca A, Villalva C, Tachon G, Rivet P, Cortes U, Guilloteau K, Balbous A, Godet J, Wager M, Karayan-Tapon L

DOI: 10.1002/cam4.1167
Published: 2017 Nov
Container: Cancer medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.1167,
  title = {Crizotinib targets in glioblastoma stem cells.},
  author = {Junca A and Villalva C and Tachon G and Rivet P and Cortes U and Guilloteau K and Balbous A and Godet J and Wager M and Karayan-Tapon L},
  year = {2017},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.1167},
  url = {https://doi.org/10.1002/cam4.1167}
}

RIS

TY  - JOUR
TI  - Crizotinib targets in glioblastoma stem cells.
AU  - Junca A
AU  - Villalva C
AU  - Tachon G
AU  - Rivet P
AU  - Cortes U
AU  - Guilloteau K
AU  - Balbous A
AU  - Godet J
AU  - Wager M
AU  - Karayan-Tapon L
PY  - 2017
JO  - Cancer medicine
DO  - 10.1002/cam4.1167
UR  - https://doi.org/10.1002/cam4.1167
ER  -

APA

A, J., C, V., G, T., P, R., U, C., K, G., A, B., J, G., M, W., & L, K. (2017). Crizotinib targets in glioblastoma stem cells.. Cancer medicine. https://doi.org/10.1002/cam4.1167

Source records

pubmed · retrieved 2026-11-10T14:52:24.608Z